Atlas FDA

Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring System

FDA premarket approval P120005/S067 · decided 2018-05-07

Approval details

PMA number
P120005
Supplement
S067
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring System
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2017-10-10
Decision date
2018-05-07
Days to decision
209 days
Decision code
APPR
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Approval for the addition of a Manufacturing Site for components of the G4 Platinum and G5 Mobile Continuous Glucose Monitoring Systems at your facility located at 232 South Dobson Rd., Mesa, Arizona.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23